A NONLETHAL CONDITIONING APPROACH TO ACHIEVE ENGRAFTMENT OF XENOGENEIC RAT BONE MARROW IN MICE AND TO INDUCE DONOR-SPECIFIC TOLERANCE1
PROLONGATION OF SURVIVAL OF PRIMARY RENAL ALLOGRAFTS BY FEEDING OF DONOR SPLEEN CELLS1
PROTECTIVE EFFECT OF EXOGENOUS NITRIC OXIDE ON THE RENAL FUNCTION AND INFLAMMATORY RESPONSE IN A MODEL OF ISCHEMIA-REPERFUSION1
ENHANCEMENT OF ENDOGENOUS CYCLIC AMP SIGNAL
THE NITRIC OXIDE DONOR SODIUM NITROPRUSSIDE IS PROTECTIVE IN ISCHEMIA/REPERFUSION INJURY OF THE PANCREAS1
LONG-TERM OUTCOME OF KIDNEY TRANSPLANTATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
TREATMENT OF OSTEOPENIA AND OSTEOPOROSIS AFTER KIDNEY TRANSPLANTATION
DOES INCREASED URINARY INTERLEUKIN-1 RECEPTOR ANTAGONIST/INTERLEUKIN-1β RATIO INDICATE GOOD PROGNOSIS IN RENAL TRANSPLANT RECIPIENTS?
GENOTYPIC VARIATION IN THE TRANSFORMING GROWTH FACTOR-β1 GENE
SIGNIFICANCE OF CYTOMEGALOVIRUS FOR LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER TRANSPLANTATION
ANALYSIS OF THE RELATIONSHIP BETWEEN CHIMERISM AND THE ALLOGENEIC HUMORAL RESPONSE1
ANALYSIS OF POSTOPERATIVE LIVER FUNCTION OF DONORS IN LIVING-RELATED LIVER TRANSPLANTATION
IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1
MANAGEMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS (FK506) THERAPY
ERYTHROCYTOSIS AFTER RENAL TRANSPLANTATION REPRESENTS AN ABNORMALITY OF INSULIN-LIKE GROWTH FACTOR-I AND ITS BINDING PROTEINS1
COMPARATIVE STUDIES OF SPECIFIC ACQUIRED SYSTEMIC TOLERANCE INDUCED BY INTRATHYMIC INOCULATION OF A SINGLE SYNTHETIC WISTAR-FURTH (RT1U) ALLO-MHC CLASS I (RT1.AU) PEPTIDE OR WAG (RT1U)-DERIVED CLASS I PEPTIDE1
EXAMINATION OF THE SENSITIVITY OF T CELLS TO FAS LIGATION
HLA ANTIBODIES PRESENT IN THE SERA OF SENSITIZED PATIENTS AWAITING RENAL TRANSPLANT ARE ALSO REACTIVE TO SWINE LEUKOCYTE ANTIGENS1,2
TRANSFER OF PORCINE MHC DRα INTO IEα-DEFICIENT MURINE BONE MARROW RESULTS IN REDUCED IE-RESTRICTED Vβ USAGE1
RELATIONSHIP BETWEEN IN VIVO FK506 CLEARANCE AND IN VITRO 13-DEMETHYLATION ACTIVITY IN LIVING-RELATED LIVER TRANSPLANTATION
STRUCTURE/FUNCTION CHARACTERIZATION OF PORCINE CD59
USE OF 2-[18F]FLUORO-2-DEOXYGLUCOSE AS A POTENTIAL AGENT IN THE PREDICTION OF GRAFT REJECTION BY POSITRON EMISSION TOMOGRAPHY1
ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL FUNCTION1
STAGE I ADENOCARCINOMA PRESENTING IN THE PNEUMONECTOMY SPECIMEN AT THE TIME OF SINGLE LUNG TRANSPLANTATION
EXTENDED DONOR CRITERIA
SERIOUS INTERACTION BETWEEN MIBEFRADIL AND TACROLIMUS1
MYCOPHENOLATE MOFETIL-INDUCED VILLOUS ATROPHY
DEMONSTRATION OF IgM ANTIBODIES OF HIGH AFFINITY WITHIN THE ANTI-GALα1-3GAL ANTIBODY REPERTOIRE
ANNOUNCEMENTS
ERRATUM
Basiliximab (Simulect™) is Efficacious in Reducing the Incidence of Acute Rejection Episodes in Renal Allograft Patients: Results at 12 Months
Basiliximab (Simulect™) Reduces Acute Cellular Rejection In Renal Allografts From Cadaveric And Living Donors
PRELIMINARY RESULTS OF THE COMBINED USE OF A HUMANIZED ANTI-IL-2Rα MONOCLONAL ANTIBODY, DACLIZUMAB (DZB), AND MYCOPHENOLATE MOFETIL (MMF) WITHOUT CALCINEURIN INHIBITORS IN RENAL TRANSPLANTATION
PHASE II CLINICAL TRIAL WITH DACLIZUMAB (ZENAPAX®) FOR PREVENTION OF ACUTE REJECTION IN LIVER TRANSPLANTED PATIENTS
TACROLIMUS AND MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS: SIX AND TWELVE MONTH RESULTS OF A MULTICENTER, RANDOMIZED DOSE RANGING STUDY
ADULT PRIMARY LIVER TRANSPLANTATION: PROSPECTIVE RANDOMIZE TRIAL OF TACROLIMUS AND STEROID VS TACROLIMUS STEROID AND MYCOPHENOLATE MOFETIL
A PROSPECTIVE RANDOMIZED TRIAL OF NEORAL AND CELLCEPT WITH AND WITHOUT OKT3 INDUCTION
12 MONTH INTENT TO TREAT ANALYSIS OF THE DOUBLE BLIND, RANDOMIZED MULTICENTER THYMOGLOBULIN VS ATGAM TRIAL FOR THE TREATMENT OF ACUTE REJECTION FOLLOWING RENAL TRANSPLANTATION
A NOVEL METHOD FOR THE STUDY OF ALLOIMMUNE RESPONSES
TRANSIENT DEPLETION OF B LYMPHOCYTES PREVENTS CHRONIC CARDIAC ALLOGRAFT REJECTION
IVIG DECREASES PRA AND ALLOWS SUCCESSFUL HEART TRANSPLANTATION IN SENSITIZED VAD RECIPIENTS
IMPORTANCE OF NATURAL KILLER T CELLS EXPRESSING CD4 FOR ACCEPTANCE OF INTRAHEPATIC RAT ISLET XENOGRAFTS IN MICE TREATED WITH ANTI-CD4 MONOCLONAL ANTIBODY
EFFECTS OF PERITRANSPLANT ADMINISTRATION OF HEMATOPOIETIC GROWTH FACTORS ON THE DEVELOPMENT OF CHRONIC REJECTION
THE USE OF MHC CLASS II-DEFICIENT MICE TO DETERMINE THE ROLE OF DIRECT VS INDIRECT ANTIGEN PRESENTATION IN THE PATHOGENESIS OF CHRONIC REJECTION
MHC COMPATIBILITY REQUIREMENTS FOR PROLONGATION OF ALLOGRAFT SURVIVAL BY POSTOPERATIVE SPLENOCYTE INFUSION
RESPONSE TO LEFLUNOMIDE TREATMENT OF EARLY CHRONIC RENAL ALLOGRAFTS REJECTION IN A RAT MODEL
THE SHRINKING RENAL REPLACEMENT THERAPY "BREAK-EVEN" POINT
DONOR BONE MARROW, CHIMERISM, HISTOCOMPATIBILITY AND RENAL ALLOGRAFT REJECTION
COST CONSIDERATIONS AND THE USE OF MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION
ANALYSIS OF MYCOPHENOLIC ACID PHARMACOKINETICS IN AFRICAN AMERICAN AND CAUCASIAN RENAL TRANSPLANT RECIPIENTS
PEDIATRIC RENAL TRANSPLANTATION UNDER TACROLIMUS-BASED IMMUNOSUPPRESSION
ICAM-1 ANTISENSE OLIGODEOXYNUCLEOTIDE BLOCKS KIDNEY ALLOGRAFT REJECTION IN CYNOMOLGUS MONKEYS
Costimulation Blockade in Non-human Primate Renal Allotransplantation
Intragraft Findings During Costimulation Blockade in Non-human Primate Renal Allotransplantation
Prevention, Reversal of Rejection and Induction of Tolerance by Monoclonal Antibody to CD45 RB in Monkey Kidney Transplant Model - A Preliminary Report
THE EFFECT OF IN-SITU SPLIT LIVER PROCUREMENT ON IMMEDIATE CADAVERIC ALLOGRAFT FUNCTION
DONOR SPLEEN CELL INFUSION INCREASES EARLY REJECTION AFTER LIVER TRANSPLANTATION
AUXILIARY ORTHOTOPIC TRANSPLANTATION AS A RESCUE FOR SMALL-FOR-SIZE GRAFTS IN LIVING-DONOR LIVER TRANSPLANT PROGRAM
A simple model to predict survival following hepatic retransplantation
EVOLVING TRENDS IN LIVER TRANSPLANTATION: AN OUTCOME AND CHARGE ANALYSIS
PRIMARY NONFUNCTION: IS IT DUE TO IMPAIRED MITOCHONDRIAL AT SYNTHESIS?
HIERARCHY OF T CELL RESPONSES TO ALLOGENEIC HEPATOCYTES
TRANSPLANTED HEPATOCYTES INFECTED WITH A COMPLEMENT RECEPTOR TYPE 1 (CR1)-CONTAINING RECOMBINANT ADENOVIRUS ARE RESISTANT TO HYPERACUTE REJECTION
THE REDUCTION OF ISCHEMIA/REPERFUSION (I/R) INJURY BY P-SELECTIN GLYCOPROTEIN LIGAND-1 (PSGL-1) IN A COLD ISCHEMIA STEATOTIC LIVER MODEL
P-SELECTIN MEDIATES REPERFUSION INJURY IN THE WARM ISCHEMIC MOUSE LIVER
The Mechanism of Injury in a Steatotic Liver Graft during Cold Preservation
INHIBITION OF THROMBOXANE A2 SYNTHETASE BY OKY-046 ATTENUATES ISCHEMIA AND REPERFUSION INJURY OF CANINE LIVERS
UPREGULATION OF PREPROENDOTHELIN-1 mRNA FOLLOWING RENAL ISCHEMIA AND REPERFUSION: IMPLICATIONS FOR TRANSPLANTATION
PHOSPHOLIPID METABOLISM IN THE HYPOTHERMIC LIVER
THE EFFECTS OF LIVER ISCHEMIA/REPERFUSION ON LEUKOCYTE ROLLING AND ADHESION
ELIMINATION OF KUPFFER CELLS AND NAFAMOSTAT MESILATE RINSE PREVENT REPERFUSION INJURY IN LIVER GRAFTS FROM AGONAL NHBD
MECHANISMS OF TOLERANCE INDUCED BY TOLEROGENIC ALLOCHIMERIC DONOR/RECIPIENT CLASS I MHC PROTEIN
Host CD8+ cells play a major role in resistance to engraftment of bone marrow for Tolerance induction
REQUIREMENT FOR IL-4 IN TOLERANCE: RESTORATION BY ADOPTIVE CELLULAR OR GENE TRANSFER
A DENDRITIC CELL LINE EXPRESSING CTLA4-IG AS A MEANS TO INACTIVATE THE ALLOREACTIVE T CELL REPERTOIRE
FUNCTIONAL RELEVANCE OF DONOR-DERIVED HEMATOPOIETIC MICROCHIMERISM ONLY FOR INDUCTION PHASE OF ALLOGRAFT ACCEPTANCE
DONOR-TYPE OR RECIPIENT-TYPE ANTIGEN PRESENTING CELLS ARE SUFFICIENT FOR INDUCTION OF RAT LIVER ALLOGRAFT TOLERANCE
T CELL ANERGY BUT NOT DELETION IS THE PREDOMINANT MECHANISM FOR INDEFINITE ISLET ALLOGRAFT SURVIVAL IN RECIPIENTS TREATED WITH rhCTLA4-Ig AND α-gp39 ANTIBODY
THE ROLE OF CLONAL DELETION IN PROLONGING SKIN ALLOGRAFT SURVIVAL IN MICE TREATED WITH ANTILYMPHOCYTE SERUM (ALS), DONOR SPECIFIC BONE MARROW (BM) AND SIROLIMUS (SIR)
APPLICABILITY OF LIVING DONOR LIVER TRANSPLANTATION TO HIGH URGENCY PATIENTS
CLINICAL INTESTINAL TRANSPLANTATION: RISK FACTORS AND NEW STRATEGIES
FEATURES OF ACUTE REJECTION THAT PREDICT INCREASED RISK FOR CHRONIC REJECTION
OUTCOME OF TRANSPLANTATION OF ORGANS PROCURED FROM BACTEREMIC OR FUNGEMIC DONORS
RAT ORTHOTOPIC LIVER TRANSPLANTS (OLT) PROTECT MHC INCOMPATIBLE DONOR TYPE PANCREATIC ISLET GRAFTS FROM ALLOGENEIC BUT NOT FROM AUTOIMMUNE DESTRUCTION
LOCAL EXPRESSION OF RECOMBINANT CTLA4IG GENE IN THE PANCREAS INDUCES PERMANENT PANCREAS GRAFT SURVIVAL AND DONOR-SPECIFIC TOLERANCE
LUNG GROWTH FOLLOWING REDUCED-SIZED LUNG TRANSPLANTATION IN A SHEEP MODEL
COMPARISON OF LOCAL VS. SYSTEMIC CTLA4Ig IN THE PROLONGATION OF ISLET XENOGRAFT SURVIVAL
PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL BY INTRATHYMIC INJECTION OF ANTI-FAS MONOCLONAL ANTIBODY
POLICY OPTIONS TO ESTABLISH EFFECTIVE DONATION PRACTICES IN HOSPITALS
ADVANCES IN DONOR MANAGEMENT
LIVER TRANSPLANT PATIENT REVIEW BY THE OHIO SOLID ORGAN TRANSPLANTATION CONSORTIUM
THE ROLE OF FLOW CYTOMETRY DETECTED IgG AND IgM ANTI-DONOR ANTIBODIES IN CARDIAC ALLOGRAFT RECIPIENTS
BRONCHIOALVEOLAR LAVAGE AND SERUM INDICATORS OF LUNG TRANSPLANT OUTCOME
USE OF ECMO IN THORACIC ORGAN TRANSPLANTATION
TRANSPLANT IMMUNOSUPPRESSION INCREASES AND PROLONGS TRANSGENE EXPRESSION IN ADENOVIRAL-MEDIATED TRANSFECTION OF RAT LUNGS
IMMUNOHISTOCHEMISTRY AND RT-PCR CONFIRM THAT BONE MARROW TRANSPLANTATION LEADS TO COMPLETE REPLACEMENT OF ORGAN APCs
67
INFLUENCE OF DONOR BRAIN DEATH ON ACUTE REJECTION OF RAT CARDIAC ALLOGRAFTS
REDUCTION OF LUNG ALLOGRAFT REPERFUSION INJURY BY TETRAHYDROBIOPTERIN (BH4), CO-ENZYME OF cNOS
SPLENIC INJECTION OF GENETICALLY-MODIFIED AUTOLOGOUS HEPATOCYTES EXPRESSING SECRETED ALLO-MHC CLASS I ANTIGEN INCREASES CD8-CELL APOPTOSIS AND REDUCES ALLO-CTL ACTIVITY
INTRAGRAFT INHIBITION OF ICAM-1 EXPRESSION BY ICAM-1 ANTISENSE OLIGODEOXYNUCLEOTIDE BLOCKS KIDNEY ALLOGRAFT REJECTION
GENE TRANSFER OF IMMUNOSUPPRESSIVE PEPTIDES B2702 AND RDP1257 PROLONGS ALLOGRAFT SURVIVAL: EVIDENCE SUGGESTING A ROLE FOR HEME OXYGENASE-I
IN VIVO DELIVERY OF AUTOLOGOUS HEPATOCYTES TRANSFECTED TO EXPRESS SECRETED DONOR-MHC CLASS I ANTIGEN PREVENTS PASSIVE TRANSFER OF HYPERACUTE HEART ALLOGRAFT REJECTION
CHARACTERIZATION OF THE IMMUNOSUPPRESSIVE EFFECT OF ASPIRIN: SHORT-TERM USE OF HIGH-DOSE ASPIRIN PERMITS PERMANENT ALLOGRAFT SURVIVAL AND INDUCTION OF DONOR-SPECIFIC TOLERANCE
INITIATION OF SIGNAL TRANSDUCER AND ACTIVATORS OF TRANSCRIPTION (STATs) FOLLOWING ISCHEMIA/REPERFUSION INJURY
TNF-MEDIATED REACTIVATION OF LATENT MURINE CYTOMEGALOVIRUS (MCMV) IN VIVO OCCURS IN THE ABSENCE OF IMMUNOSUPPRESSION
LONG-TERM COMPOSITE TISSUE ALLOGRAFT SURVIVAL IN A NOVEL PORCINE MODEL WITH CYCLOSPORINE (CSA)/MYCOPHENOLATE MOFETIL (MMF) THERAPY
A NEW ALLOCATION PLAN FOR RENAL TRANSPLANTATION
THE FEASIBILITY OF NATIONAL SHARING OF CADAVERIC ISOLATED INTESTINAL ALLOGRAFTS FOR HUMAN TRANSPLANTATION
CHARACTERISTICS AND FUNCTION OF KIDNEYS OFFERED AS PAYBACKS TO A REGIONAL ORGAN PROCUREMENT ORGANIZATION
IDENTIFICATION OF KIDNEYS SUBJECTED TO PRE-RETRIEVAL WARM ISCHEMIC INJURY DURING HYPOTHERMIC PERFUSION PRESERVATION
SUCCESSFUL SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION WITH DONORS LESS THAN 10 YEARS OLD
ABLATING THE ISCHEMIA-REPERFUSION INJURY IN NON-HEART BEATING DONOR (NHBD) KIDNEYS
Kidney Transplantation Without a Final Crossmatch
BENEFICIAL EFFECT OF VOLUME EXPANSION ON THE ALTERED RENAL HEMODYNAMICS OF PROLONGED PNEUMOPERITONEUM
A PROSPECTIVE COMPARISON OF SYSTEMIC-BLADDER VERSUS PORTAL-ENTERIC DRAINAGE IN VASCULARIZED PANCREAS TRANSPLANTATION
ENTERIC DRAINAGE VS. BLADDER DRAINAGE IN THE MYCOPHENOLATE ERA: A COMPARISON OF OUTCOME IN SIMULTANEOUS KIDNEY PANCREAS (SPK) TRANSPLANTATION
RANDOMIZED MULTICENTER OPEN LABEL COMPARATIVE TRIAL OF MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION
LONG TERM RESULTS OF PANCREAS TRANSPLANTATION UNDER TACROLIMUS IMMUNOSUPPRESSION
SURGICAL COMPLICATIONS REQUIRING EARLY RELAPAROTOMY AFTER PANCREAS (Pa) TRANSPLANTATION (Tx): COMPARISON OF THE FK AND CsA ERA
HLA MATCHING IS UNNECESSARY IN SOLITARY PANCREAS TRANSPLANTATION
LOW IMMUNOLOGIC FAILURE RATE OF SOLITARY PANCREAS TRANSPLANTS WITH PORTAL VENOUS DRAINAGE
STRATEGIES TO EXPAND THE DONOR POOL FOR PANCREAS TRANSPLANTATION
RESULTS OF PRIMARY ISOLATED INTESTINAL TRANSPLANTATION: A 4-YEAR EXPERIENCE
TRANSIENT ISCHEMIA/REPERFUSION INJURY INDUCES CHRONIC MORPHOLOGICAL ALTERATIONS IN THE SMALL BOWEL
PORTAL VERSUS SYSTEMIC VENOUS DRAINAGE OF INTESTINAL ALLOGRAFTS IN HUMANS
IMMUNOMODULATION OF INTESTINAL TRANSPLANTATION WITH ALLOGRAFT IRRADIATION AND SIMULTANEOUS DONOR BONE MARROW INFUSION
LYMPHATIC RECONSTRUCTION HAS A LONG TERM BENEFIT AFTER INTESTINAL TRANSPLANTATION IN RATS
DIFFERENTIAL EFFECT OF ANTI-CD8 MONOCLONAL ANTIBODY THERAPY ON MURINE INTESTINE AND CARDIAC ALLOGRAFTS
SHORT COURSE TREATMENT OF CYCLOPHOSPHAMIDE INDUCES LONG TERM SURVIVAL OF INTESTINAL ALLOGRAFTS IN MICE
REGENERATIVE SIGNALS FOR INTESTINAL EPITHELIAL ORGANOID UNITS TRANSPLANTED ON SYNTHETIC BIODEGRADABLE POLYMER SCAFFOLDS FOR THE TISSUE ENGINEERING OF SMALL INTESTINE
SUCCESSFUL ANASTOMOSIS BETWEEN TISSUE-ENGINEERED INTESTINE AND NATIVE SMALL BOWEL
ABNORMAL HUMAN MONOCYTE ACTIVATION BY CARBOHYDRATE LIGANDS ON PORCINE ENDOTHELIUM, AND REVERSAL BY OVEREXPRESSION OF FUCOSYL α1,2 TRANSFERASE
TARGET CELL SUSCEPTIBILITY TO LYSIS BY HUMAN NATURAL KILLER CELLS IS AUGMENTED BY α1,3-GALACTOSYLTRANSFERASE AND REDUCED BY α1,2-FUCOSYLTRANSFERASE
ANTISENSE RIBOZYME-MEDIATED CLEAVAGE OF α-1,3-GALACTOSYLTRANSFERASE mRNA: A MECHANISM FOR REDUCTION OF THE α-1,3-GALACTOSYL EPITOPE
IN BABOON, A COMPLETE ELIMINATION OF THE CIRCULATING IgM BY ANTI-µ MONOCLONAL ANTIBODY ALLOWS A PIG KIDNEY XENOGRAFT TO SURVIVE UP TO SIX DAYS WITHOUT ADDITIONAL IMMUNOSUPPRESSION
PREVENTION OF INITIAL PERFUSION FAILURE AND OF FUNCTIONAL DEFICIT IN XENOGENEIC EX-VIVO PERFUSED LIVERS BY INHIBITION OF SELECTIN-MEDIATED CELL INTERACTIONS
TRANSFER OF PERV RNA THROUGH HOLLOW FIBER MEMBRANES: SIGNIFICANCE TO A BIOARTIFICIAL LIVER
CLINICAL APPLICATIONS OF PIG ENDOGENOUS RETROVIRAL (PERV) RNA QUANTITATION
VALIDATION OF THE MOUSE-TO-RABBIT COMBINATION AS A MODEL FOR PIG-TO-PRIMATE XENOTRANSPLANTATION
DIVERGENT EFFECTS OF INTRATHYMIC IMMUNOMODULATION ON CELLULAR AND HUMORAL ALLOREACTIVITY IN TRANSPLANT RECIPIENTS
CLONAL DELETION AND TOLERANCE AFTER IN UTERO BONE MARROW TRANSPLANTATION IN MICE
INDUCTION OF TOLERANCE BY FEEDING RECIPIENTS WITH DONOR/RECIPIENT CLASS I MHC ALLOCHIMERIC PROTEINS
SECRETED DONOR MHC ANTIGEN EXPRESSED AFTER GENE TRANSFER PREVENTS ACCELERATION OF LIVER ALLOGRAFT REJECTION INDUCED BY MEMBRANE-BOUND DONOR ANTIGEN
SIROLIMUS (SIR) FACILITATES INDUCTION OF CHIMERISM IN ANTILYMPHOCYTE SERUM (ALS) TREATED, DONOR SPECIFIC BONE MARROW (BM) INJECTED MICE
E. COLI-PRODUCED SOLUBLE MHC CLASS I PROTEINS INDUCE POTENT ALLOANTIGEN-SPECIFIC IN VIVO EFFECTS
PATTERN OF ALLORECOGNITION AND ACCEPTANCE OF SAME DONOR ALLOGRAFT FOLLOWING TOLERANCE INDUCED BY HEPATIC TRANSDUCTION WITH AdCTLA4Ig
MECHANISMS OF PREVENTING XENOGRAFT REJECTION BY MONOCLONAL ANTIBODY TO CD45RB AND CYCLOPHOSPHAMIDE IN A RAT TO MOUSE KIDNEY TRANSPLANT MODEL
LONGTERM 3D COLLAGEN SPONGE MATRIX ISLET CULTURE-THE EFFECT OF HEPATOCYTE COCULTURE
LARGE SCALE ISOPYCNIC ISLET PURIFICATION UTILIZING NON-TOXIC, ENDOTOXIN-FREE MEDIA FACILITATES IMMEDIATE SINGLE-DONOR PIG ISLET ALLOGRAFT FUNCTION
ADENOVIRAL-MEDIATED DELIVERY OF THE HUMAN iNOS GENE TO LIVER ISOGRAFTS: AN IMPROVED MODEL OF EX-VIVO GENE TRANSFER
RESISTANCE OF ISLET XENOGRAFTS TO HUMORAL REJECTION
REGULATORY T CELLS MAINTAIN PERIPHERAL TOLERANCE TO ISLET ALLOGRAFTS INDUCED BY INTRATHYMIC INJECTION OF MHC CLASS I ALLOPEPTIDES
PRETREATMENT OF ISLETS WITH MITOMYCIN C (MMC) AND BLOCKAGE OF DIRECT ANTIGEN PRESENTATION INDUCE UNRESPONSIVENESS TO ISLET XENOGRAFT
DISCORDANT ISLET XENOTRANSPLANTATION; LONG-TERM SURVIVAL FOLLOWING SHORT-TERM TREATMENT WITH ANTI-CD45RB AND CYCLOPHOSPHAMIDE
FAILURE OF TOLERANCE INDUCTION BY ISLET TRANSPLANTATION IN "LOW RESPONDER" RAT COMBINATION WITH MHC CLASS I DISPARITY
WHY DON'T WOMEN HAVE EQUAL ACCESS TO KIDNEY TRANSPLANTATION (Txp)?
LIVING-RELATED LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE IN CHILDREN: A SINGLE-CENTER EXPERIENCE
THIRD TRANSPLANT KIDNEY GRAFTS - OUTCOME ANALYSIS
USE OF ORGAN GRAFTS PROCURED IN ORGAN TRANSPLANT RECIPIENTS
RACE/ETHNIC-BASED OPINIONS ON ORGAN DONATION AND TRANSPLANTATION AMONG TEENS: PRELIMINARY RESULTS
IMPACT OF PUBLIC SCHOOL-BASED TEACHING ON STUDENTS' OPINIONS ON ORGAN DONATION AND TRANSPLANTATION
INCREASING CONSENT BY PROVIDING ACCURATE INFORMATION
MARGINAL DONORS AND LIVER TRANSPLANTATION: JUSTIFICATION FOR THEIR USE
SIMILAR OUTCOMES, MORBIDITY, AND MORTALITY FOR ORTHOTOPIC LIVER TRANSPLANTATION BETWEEN VERY ELDERLY AND YOUNG AGE-MATCHED CONTROLS
LONG-TERM RESULTS OF LIVER TRANSPLANTATION IN PATIENTS 60 YEARS OF AGE AND OLDER
RETRANSPLANTATION FOR LATE LIVER GRAFT FAILURE: PREDICTORS OF MORTALITY
RETRANSPLANTATION OF THE LIVER: A SINGLE CENTER EXPERIENCE
MORBID OBESITY IS NOT AN INDEPENDENT RISK FACTOR FOR LIVER TRANSPLANTATION
LIVER TRANSPLANTATION FOR MALIGNANCY IN PEDIATRIC PATIENTS
Increased Incidence of GI Surgical Complications in Renal Transplant Recipients with Polycystic Kidney Disease
EFFECTS OF VESICOURETERAL REFLUX ON THE TRANSPLANTED KIDNEY
VASCULAR GRAFT THROMBOSIS AFTER PANCREAS TRANSPLANTATION: COMPARISON OF THE FK AND CsA ERA
EXPERIENCE WITH RELAPAROTOMY AFTER PANCREAS TRANSPLANTATION WITH PORTAL-ENTERIC DRAINAGE
POOR OUTCOME ASSOCIATED WITH ACUTE PANCREATITIS IN PATIENTS WITH FULMINANT HEPATIC FAILURE
THE INFLUENCE OF RENAL TRANSPLANTATION ON PERIPHERAL VASCULAR OCCLUSIVE DISEASE
RECIPIENT SYMPTOMATIC PERIPHERAL VASCULAR DISEASE HAS A DELETERIOUS EFFECT ON CADAVER DONOR RENAL TRANSPLANTS
Different Roles for α4-Integrin/VCAM-1 and α4/Fibronectin Interactions in Allograft Rejection
SYSTEMIC ADMINISTRATION OF CTLA4-Ig OR ANTI-CD40 LIGAND ANTIBODY INHIBITS SECOND-SET REJECTION OF MOUSE LIVER ALLOGRAFTS
FAS AND FAS-L MEDIATED CYTOTOXICITY IN ALLOGRAFT REJECTION
SYNERGISTIC EFFECTS OF ANTI-TRANSFERRIN RECEPTOR AND ANTI-IL-2 RECEPTOR MONOCLONAL ANTIBODIES ON T CELL RESPONSES TO ALLOANTIGEN
LONG-TERM ALLOGRAFT ACCEPTANCE INDUCED BY AN ANTIBODY AGAINST A COMMON LEUKOCYTE ANTIGEN IN A RAT TRANSPLANT MODEL
p21ras INHIBITORS: A NEW CLASS OF IMMUNOSUPPRESSIVE AGENTS?
1,25-DIHYROXYVITAMIN D3-INDUCED PROLONGATION OF GRAFT SURVIVAL WITHOUT INCREASED SUSCEPTIBILITY TO OPPORTUNISTIC INFECTION MAY BE MEDIATED BY ALTERED ANTIGEN PRESENTATION
IN VIVO GENERATION OF C4d, Bb, iC3b, AND SC5b-9 AFTER OKT3 ADMINISTRATION: CORRELATION BETWEEN COMPLEMENT ACTIVATION AND PULMONARY HEMODYNAMIC CHANGES
Autoimmune Recurrence in the Pancreatic Allografts: Chimerism by the NKT Immunoregulatory Cells
COMBINED TROPHIC FACTORS PROMOTE SUCCESS OF FETAL PANCREAS (FP) GRAFTS
ISLET-SPLENOCYTE CO-TRANSPLANTATION ABOLISHES AUTOIMMUNE-DRIVEN PRIMARY NON-FUNCTION IN THE NON-OBESE DIABETIC MOUSE
PROTECTION OF ISLET ALLOGRAFTS TRANSPLANTED TOGETHER WITH FAS LIGAND EXPRESSING TESTICULAR ALLOGRAFTS
EFFICIENT GENE TRANSFER AND EXPRESSION IN ISLETS BY AN ADENOVIRAL VECTOR THAT LACKS ALL VIRAL GENES
ANALYSIS OF ADENOVIRAL MEDIATED GENE TRANSFER TO PANCREATIC ISLETS BY VASCULAR PERFUSION OF THE INTACT PANCREAS PRIOR TO ISLET ISOLATION
REVERSAL OF DIABETES IN STREPTOZOTOCIN TREATED RATS BY HEMATOPOIETIC STEM CELLS EXPOSED TO RECOMBINANT ADENO-ASSOCIATED VIRUS CONTAINING RAT PREPROINSULIN II GENE
ISLET ALLOGRAFT FUNCTION IN DIABETIC NON-HUMAN PRIMATES TREATED WITH HUMANIZED ANTI-CD154(5C8)
LONG-TERM RENAL FUNCTION OF NON-HEART-BEATING DONOR KIDNEY TRANSPLANTATION. A SINGLE-CENTER EXPERIENCE
THE IMPACT OF DONOR AGE ON THE MORTALITY RISK OF TRANSPLANTATION VS. REMAINING ON THE WAITING LIST (WL) FOR KIDNEY AND KIDNEY/PANCREAS (K/P) PATIENTS
SHOULD A LIVING-DONOR KIDNEY TRANSPLANT TAKE PRIORITY OVER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT?: A COST-EFFECTIVENESS ANALYSIS
LAPAROSCOPIC VS. OPEN DONOR NEPHRECTOMY: COMPARING URETERAL COMPLICATIONS IN THE RECIPIENTS AND IMPROVING THE LAPAROSCOPIC TECHNIQUE
A MODIFIED, OPEN, LIVING-DONOR NEPHRECTOMY TECHNIQUE: IS IT BETTER THAN LAPAROSCOPIC DONOR NEPHRECTOMY?
WHAT IS THE IDEAL INTERVENTION FOR URETERAL OBSTRUCTION/STRICTURE?
VALIDATION OF SELECTION CRITERIA FOR DOUBLE RENAL ALLOGRAFTS: 2 YEAR RESULTS
MULTILAMELLATION OF THE PERITUBULAR CAPILLARY BASEMENT MEMBRANE IN CHRONIC RENAL ALLOGRAFT REJECTION
PRIMARY LIVER TRANSPLANTATION UNDER TACROLIMUS IN INFANTS, CHILDREN, ADULTS AND SENIORS: 1000 CONSECUTIVE PATIENTS FROM SINGLE CENTRE WITH 5 TO 8 YEARS ACTUAL FOLLOW-UP
ORTHOTOPIC LIVER TRANSPLANTATION FOR METABOLIC LIVER DISEASE IN THE PEDIATRIC PATIENT
A PROSPECTIVE TRIAL OF PRE-TRANSPLANT CHEMOEMBOLIZATION FOR THE TREATMENT OF STAGE 3 AND 4a HEPATOMA
HEPATOCELLULAR CARCINOMA RECURRENCE FOLLOWING LIVER TRANSPLANTATION
TACROLIMUS DOSE IS DONOR AGE DEPENDENT
EXCISION AND IMMEDIATE REVASCULARIZATION FOR HEPATIC ARTERY PSEUDOANEURYSM FOLLOWING LIVER TRANSPLANTATION
PRECLINICAL EVALUATION OF A NOVEL BIOARTIFICIAL LIVER USING A CANINE D-GALACOSAMINE LIVER FAILURE MODEL
HEPATOCYTE TRANSPLANTATION IMPROVES LIVER FUNCTION AND PROLONGS SURVIVAL IN RATS WITH DECOMPENSATED LIVER CIRRHOSIS
ENHANCED mRNA EXPRESSION OF THE CHEMOKINE, MCP-1, IN ENDOMYOCARDIAL BIOPSY SPECIMENS FROM PATIENTS WITH ACUTE CARDIAC ALLOGRAFT REJECTION
MAINTENANCE IMMUNOSUPPRESSION WITH CYCLOSPORINE MONOTHERAPY IN LIVER TRANSPLANT ADULT RECIPIENTS
PROLONGATION OF CARDIAC ALLOGRAFT SURVIVAL BY POSTOPERATIVE INFUSION OF DONOR LEUKOCYTES
THE PHARMACOKINETIC AND CLINICAL IMPLICATIONS OF THE ENHANCED BIOAVAILABILITY OF THE MICROEMULSION FORMULATION OF CYCLOSPORINE (NEORAL®)
INHIBITION OF TRANSPLANT VASCULOPATHY BY PRAVASTATIN IS ASSOCIATED WITH ATTENUATION OF HOST ALLO-ANTIBODY RESPONSES
THE EFFECTS OF HEART/KIDNEY VS DOUBLE HEART TRANSPLANTATION ON TOLERANCE INDUCTION AND PREVENTION OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) IN MINIATURE SWINE
T CELL DIRECTED IMMUNOTHERAPY AND HEPATOCYTE TRANSPLANTATION
EFFECT OF FLT-3 LIGAND ON ALLOGENEIC CHIMERISM AFTER ORGAN TRANSPLANTATION: LYMPHOID AND NONLYMPHOID COMPARTMENTATION OF CHIMERISM
VASCULAR REJECTION AFTER ARTERIAL TRANSPLANTATION AND PERIPHERAL LYMPHOID RECONSTITUTION IN SCID MICE
AN IN VITRO RNA AMPLIFICATION STRATEGY ALLOWS CDNA MICROARRAY ANALYSIS OF SMALL AMOUNTS OF TISSUE
DISTURBANCES OF ACID-BASE BALANCE FOLLOWING DISCORDANT GUINEA PIG→ RAT LIVER XENOTRANSPLANTATION
The Contribution of Humoral Immune Response to the Pathogenesis of Acute Vascular Rejection
CHICKEN ANTIBODIES FOR THE SOUL-POTENTIAL BLOCKING ANTIBODIES FOR XENOGRAFT REJECTION?
SHORT TERM ANTILYMPHOCYTE SERUM, RAPAMYCIN AND DONOR BONE MARROW SIGNIFICANTLY SUPPRESS ANTIDONOR ANTIBODY AND PROLONG HAMSTER-TO-RAT CARDIAC XENOGRAFT SURVIVAL
REGENERATIVE POTENTIAL IN LIVER TISSUE OF PATIENTS WITH FULMINANT HEPATIC FAILURE (FHF) FOLLOWING TREATMENT WITH BIOARTIFICIAL LIVER
LATE CONVERSION TO TACROLIMUS IN LIVER RECIPIENTS WITH CYCLOSPORINE-RELATED SIDE EFFECTS
COMPARABLE OUTCOMES FOR ABO NON-IDENTICAL AND INCOMPATIBLE GRAFTS IN LIVER TRANSPLANTATION
THE EFFECT OF MAINTENANCE DOSES OF FK506 VERSUS CSA ON GLUCOSE AND LIPID METABOLISM AFTER ORTHOTOPIC LIVER TRANSPLANTATION
EXPANDING THE DONOR POOL: SAFE USE OF DONORS WITH POSITIVE HEPATITIS B CORE ANTIBODY
EFFECTIVENESS OF PREOPERATIVE CHEMO-EMBOLIZATION FOR HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANT CANDIDATES
COMBINED LIVER AND KIDNEY TRANSPLANTATION (LKT) IN CHILDREN
RESCUE THERAPY FOR LIVER RECIPIENTS WITH RECURRENT HEPATITIS B
NATURAL HISTORY OF HEPATITIS C RECURRENCE IN ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS FOR HEPATITIS C ALONE VS HEPATITIS C AND ALCOHOLIC CIRRHOSIS
A Prospective Longitudinal Analysis of ATGAM Induction Versus Mycophenolate Mofetil Maintenance Immunosuppression for Orthotopic Liver Transplantation
A SELECTIVE DEFECT IN NEORAL AND PROGRAF ABSORPTION WITH AN INTESTINAL ALLOGRAFT DUE TO INCREASED MUCOSAL P-GLYCOPROTEIN ACTIVITY
RECURRENT HEPATITIS B: PREDICTORS AND PROPHYLAXIS FOLLOWING LIVER TRANSPLANTATION
THE PIGGYBACK TECHNIQUE WITHOUT PORTOCAVAL SHUNT IS SUPERIOR TO STANDARD VENO-VENO BYPASS TECHNIQUE FOR LIVER TRANSPLANTATION
UTILITY OF THE BANFF INTERNATIONAL CONSENSUS SCHEMA IN DIAGNOSING CHRONIC LIVER ALLOGRAFT REJECTION
EARLY ACUTE REJECTION AND LATE GRAFT LOSS: AN ANALYSIS OF PAIRED CADAVER KIDNEYS
LIVING RELATED RENAL ALLOGRAFTS RARELY PROGRESS FROM ACUTE TO CHRONIC REJECTION
SINGLE PEDIATRIC DONOR KIDNEYS FOR ADULTS: FACTORS IN SHORT AND LONG TERM OUTCOMES
EFFECTS OF ERYTHROPOIETIN(EP), ANGIOTENSIN II(AII), AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR(ACEI) ON BURST-FORMING UNITS-ERYTHROID(BFU-E) WITH POST TRANSPLANT ERYTHROCYTOSIS(PTE)
PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE TREATMENT FOR REFRACTORY HUMORAL REJECTION IN RENAL ALLOGRAFTS
THE CLINICAL USEFULNESS OF THE ALLOGRAFT BIOPSY IN THE CYCLOSPORINE ERA: A PROSPECTIVE STUDY
THE ROLE OF SPLENECTOMY IN A NON-LETHAL PREPARATIVE REGIMEN FOR INDUCTION OF TOLERANCE IN NON-HUMAN PRIMATES
THE EFFECT OF PROLONGED PRE-TRANSPLANTATION DIALYSIS ON GRAFT SURVIVAL IN FIRST CADAVERIC TRANSPLANT RECIPIENTS
COMPLETELY REVERSED ACUTE REJECTION (AR) IS NOT A SIGNIFICANT RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC REJECTION (CR) IN RENAL TRANSPLANT RECIPIENTS
Mycophenolate Mofetil Improves Long Term Graft Survival Following Renal Transplantation in Patients Experiencing Delayed Graft Function
PHARMACOKINETICS AND SAFETY OF MEDI-507, A HUMANIZED ANTI-CD2 MONOCLONAL ANTIBODY IN RENAL ALLOGRAFT RECIPIENTS
The Older Renal Transplant Recipient: Advantage or Disadvantage of Decreased Clinical Immune Responsiveness
CHRONIC CYCLOSPORINE NEPHROTOXICITY IS NOT CLINICALLY RELEVANT IN LONG TERM ALLOGRAFT FUNCTION OR SURVIVAL
MACHINE PERFUSION PRESERVATION DOES NOT INCREASE THE RISK OF KIDNEY GRAFT REJECTION
IPSILATERAL RETROPERITONEAL DOUBLE CADAVERIC (DBLCAD) TRANSPLANTS: A METHOD FOR EXTENDING THE USE OF MARGINAL DONORS
DISPARATE EARLY FUNCTION IN MATCHED KIDNEYS IS NOT DUE TO RACIAL OR PANEL REACTIVE ANTIBODY (PRA) DIFFERENCES
TACROLIMUS IS EFFECTIVE AND SAFE FOR RESCUE IN BOTH "LOW RISK" AND "HIGH RISK" PATIENTS
SUCCESSFUL LIVING UNRELATED KIDNEY DONATION - TRANSPLANTATION: A FOUR YEAR EXPERIENCE
OKT3 Largely Abrogates The Adverse Effect of first Rejection Episodes in Synchronous Pancreas-Kidney (SPK) Transplantation If Recurrent Rejection Is Avoided
SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (SPK): LIVING RELATED DONOR VS. CADAVER DONOR
RESOLUTION OF HYPERGLYCEMIA IN PANCREAS TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS
CENTER SPECIFIC THORACIC GRAFT AND PATIENT SURVIVAL RATES
LVAD BRIDGE TO HEART TRANSPLANT THERAPY: EFFECTS ON OUTCOME, WAITING TIME, CENTER VOLUME, AND DONOR RESOURCE ALLOCATION
RISKS OF HEPATIC ARTERY AND PORTAL VEIN THROMBOSIS IN PEDIATRIC TRANSPLANTATION: TECHNICAL ASPECTS
DACLIZUMAB RAPIDLY Y SATURATES THE INTERLEUKIN-2 RECEPTOR-α (CD25) ON LYMPH NODE LYMPHOCYTES IN CHILDREN
EXPRESSION OF THE EPITHELIAL CELL-SPECIFIC INTEGRIN, CD103, BY CD8 CELLS THAT INFILTRATE REJECTING ALLOGRAFTS IN A NON-VASCULARIZED MOUSE KIDNEY TRANSPLANT MODEL
Splenic and Skin Chimerism in the Rat Tolerant to a Renal Allograft
Cytokine Expression in a Stringent, Single-dose Rapamycin, Renal Allograft Model
IN VIVO GENE TRANSFER TO THE ADULT PANCREAS
NUTRITIONAL AND HORMONAL SUPPLEMENTATION INCREASES GLYCOGEN AND PROTEIN SYNTHESIS IN THE ALLOGRAFT IMMEDIATELY AFTER LIVER TRANSPLANTATION
BILIARY FIBROSIS IN THE TRANSPLANTED LIVER: ROLE OF RECIPIENT FACTORS
CEREBRAL HYPEREMIA AND BRAIN EDEMA IN EXPERIMENTAL ACUTE LIVER FAILURE (ALF)
ORIGIN, KINETICS, AND FUNCTION OF CHIMERIC B LYMPHOCYTES IN LIVER ALLOGRAFTS
CYTOKINE EXPRESSION AND T CELL INFILTRATION AFTER ISCHEMIC PRESERVATION INJURY OF RAT CARDIAC GRAFTS
EQUIVALENT RENAL ALLOGRAFT FUNCTION WITH LAPAROSCOPIC VERSUS OPEN LIVE DONOR NEPHRECTOMIES
APOPTOSIS MANIFESTS IN LUNGS DURING REPERFUSION RATHER THAN ISCHEMIA
PROTECTIVE EFFECT OF ISCHEMIC-PRECONDITIONING ON LIVER PRESERVATION-REPERFUSION INJURY IN RATS
INTERFERENCE WITH T CELL ACTIVATION SIGNAL ONE AND SIGNAL TWO WITH A COMBINATION OF ANTI-CD45RB AND ANTI-CD40L MONOCLONAL ANTIBODIES INDUCES LONG-TERM ISLET ALLOGRAFT SURVIVAL IN MICE
COMPARISON OF JEJUNAL AND ILEAL SURVEILLANCE BIOPSIES IN A PORCINE MODEL OF BOWEL TRANSPLANTATION
THE GALACTOSE α1,3 GALACTOSYLTRANSFERASE (GalT) KNOCK OUT MOUSE IS NOT AN INNATE MODEL FOR HUMAN HYPERACUTE REJECTION: PROBLEMS DEFINED AND SOLUTIONS PROFFERED